Headley Jan M, Ahrens Thomas
Jan M. Headley is Principal, Consultants in Acute and Critical Care, PTY 880853, PO Box 025724, Miami, FL 33102-5724 (
Thomas Ahrens is Chief Learning Officer, NovEx, St Louis, Missouri.
AACN Adv Crit Care. 2020 Mar 15;31(1):25-33. doi: 10.4037/aacnacc2020992.
The year 2020 marks the 50th anniversary of the landmark publication on the bedside clinical use of a flow-directed catheter. The catheter, now known as the Swan-Ganz catheter, truly revolutionized practice and care of the critically ill. Use of the catheter proliferated nearly without rigorous validation or evidence base until a moratorium was called in regard to its use. This article describes the history of the development of the Swan-Ganz catheter, its uses, and its near downfall. The authors, both involved in educating clinicians in the use of the pulmonary artery catheter, hope that telling this story shares tribal knowledge and lessons learned with newer generations of nurses who did not experience the explosion of development and knowledge in the area of hemodynamic monitoring. Partly because of advances in technology, and the catheter's application for heart failure in particular, use of the pulmonary catheter is being resurrected.
2020年是关于血流导向导管床边临床应用的具有里程碑意义的出版物发表50周年。这种导管,即现在所知的Swan-Ganz导管,确实彻底改变了危重症患者的治疗实践和护理方式。在叫停该导管的使用之前,其应用几乎是在没有严格验证或循证基础的情况下迅速扩散开来。本文描述了Swan-Ganz导管的发展历程、用途及其险些走向衰落的情况。两位作者都参与了对临床医生进行肺动脉导管使用方面的培训,他们希望讲述这个故事能将行业知识和经验教训分享给新一代护士,这些护士没有经历过血流动力学监测领域的快速发展和知识爆炸。部分由于技术进步,尤其是该导管在心力衰竭治疗中的应用,肺动脉导管的使用正在复兴。